Millennium Management »

Kalaris Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $144k 25k 5.78
2025-06-30 $144k 54k 2.67
2025-03-31 $133k 17k 8.03

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial Call Option (XLF)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Millennium Management

Top funds holding Kalaris Therapeutics

Samsara BioCapital
Tang Capital Management
Siren
Woodline Partners
Vanguard Group
Renaissance Technologies
Redmile Group
Geode Capital Management
BlackRock
Squarepoint Ops
Fortis Capital Advisors
Belpointe Asset Management
Millennium Management
State Street Corporation
Bridgeway Capital Management

View all funds holding Kalaris Therapeutics